%0 Journal Article
%T Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data
%A Albrecht Gr£¿ner
%A Christine Joch
%A Cristina Solomon
%A Dietmar Fries
%A Ingvild Birschmann
%A Inna Pendrak
%A Wolfgang Korte
%J Archive of "Transfusion Medicine and Hemotherapy".
%D 2016
%R 10.1159/000446813
%X Plasma-derived factor XIII (FXIII) concentrate is an effective treatment for FXIII deficiency. We describe adverse drug reactions (ADRs) reported during pharmacovigilance monitoring of Fibrogammin£¿/Corifact£¿ and review published safety data
%K Factor XIII
%K Pharmacovigilance
%K Safety
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073543/